Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Active Plaque Psoriasis”

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT04435600
What this trial is testing

Subcutaneous Risankizumab Injection for Pediatric Participants With Moderate to Severe Plaque Psoriasis to Assess Change in Disease Symptoms

Who this might be right for
Psoriasis
AbbVie 139
Large-scale testing (Phase 3)Study completedNCT02684357
What this trial is testing

BI 655066 Versus Placebo & Active Comparator (Ustekinumab) in Patients With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
AbbVie 577
Large-scale testing (Phase 3)Active Not RecruitingNCT03451851
What this trial is testing

Evaluate the Efficacy, Safety, and Pharmacokinetics of Subcutaneously Administered Guselkumab for the Treatment of Chronic Plaque Psoriasis in Pediatric Participants

Who this might be right for
Psoriasis
Janssen Research & Development, LLC 120
Large-scale testing (Phase 3)Active Not RecruitingNCT06425549
What this trial is testing

Evaluate the Efficacy and Safety of Bimekizumab Compared to Ustekinumab in Children and Adolescents From 6 Years to Less Than 18 Years of Age With Moderate to Severe Plaque Psoriasis

Who this might be right for
Moderate to Severe Plaque Psoriasis
UCB Biopharma SRL 176
Early research (Phase 1)Study completedNCT05522816
What this trial is testing

KX01 Ointment Phase 1 Study in Patients With Plaque Type Psoriasis

Who this might be right for
Psoriasis
PharmaEssentia 28
Large-scale testing (Phase 3)Study completedNCT06108544
What this trial is testing

A Study About How Well TAK-279 Works and Its Safety in Participants With Moderate-to-severe Plaque Psoriasis During 60 Weeks of Treatment With a Withdrawal and Retreatment Period

Who this might be right for
Plaque Psoriasis
Takeda 1,108
Testing effectiveness (Phase 2)Study completedNCT01045577
What this trial is testing

A Double-blind, Placebo-controlled, Randomized, Parallel-group Study to Evaluate the Activity of Oral AB1010 in Adults Patients With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
AB Science 25
Testing effectiveness (Phase 2)Study completedNCT02180464
What this trial is testing

A Intra-individual Comparison to Investigate the Efficacy and the Safety of LAS41004 Formulation in Mild to Moderate Psoriasis

Who this might be right for
Psoriasis
Almirall, S.A. 40
Testing effectiveness (Phase 2)Study completedNCT01360944
What this trial is testing

Exploratory Study to Investigate Efficacy of LAS41004 in a Psoriasis Plaque Test

Who this might be right for
Psoriasis
Almirall, S.A. 22
Large-scale testing (Phase 3)Study completedNCT06588738
What this trial is testing

A Study in Patients With Moderate to Severe Plaque Psoriasis to Evaluate the Efficacy and Safety of ESK-001

Who this might be right for
Plaque Psoriasis
Alumis Inc 862
Large-scale testing (Phase 3)Active Not RecruitingNCT06630559
What this trial is testing

Compare Efficacy and Safety of CT-P55 and Cosentyx in Patients With Moderate to Severe Psoriasis

Who this might be right for
Plaque Psoriasis
Celltrion 153
Large-scale testing (Phase 3)Study completedNCT02134210
What this trial is testing

Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Chronic Plaque Psoriasis (PsO)

Who this might be right for
Plaque Psoriasis
Coherus Oncology, Inc. 521
Large-scale testing (Phase 3)Study completedNCT03849404
What this trial is testing

Efficacy, Safety, and Immunogenicity of AVT02 With Moderate-to-Severe Chronic Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Alvotech Swiss AG 413
Large-scale testing (Phase 3)Study completedNCT03316781
What this trial is testing

Study of Efficacy and Safety of HLX03 in Subjects With Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Shanghai Henlius Biotech 262
Early research (Phase 1)Study completedNCT01235728
What this trial is testing

Evaluate and Compare the Efficacy and Pharmacokinetics of MK-0873 for the Treatment of Plaque Psoriasis (MK-0873-022)

Who this might be right for
PsoriasisPlaque Psoriasis
Merck Sharp & Dohme LLC 24
Large-scale testing (Phase 3)Study completedNCT02850965
What this trial is testing

Efficacy, Safety and Immunogenicity of BI 695501 Versus Humira® in Patients With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
Boehringer Ingelheim 318
Large-scale testing (Phase 3)Study completedNCT02684370
What this trial is testing

BI 655066 (Risankizumab) Compared to Placebo and Active Comparator (Ustekinumab) in Patients With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
AbbVie 560
Large-scale testing (Phase 3)Looking for participantsNCT07724366
What this trial is testing

A Clinical Trial of TQH3906 Capsules in Adult Patients With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. 400
Early research (Phase 1)Study completedNCT02435342
What this trial is testing

A 4 Week Study of the Safety, Tolerability, and Pharmacodynamics of ShK-186 (Dalazatide) in Active Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Kineta Inc. 24
Large-scale testing (Phase 3)Study completedNCT03624127
What this trial is testing

Effectiveness and Safety of BMS-986165 Compared to Placebo and Active Comparator in Participants With Psoriasis

Who this might be right for
Psoriasis
Bristol-Myers Squibb 666
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation